Everolimus (EVE) + letrozole (LET) in patients (pts) with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4
Bachelot T., Royce M., Villanueva C., Melo Cruz F., Hegg R., Falkson C., ...More
Annals of Oncology, vol.28, 2017 (SCI-Expanded, Scopus)
-
Publication Type:
Article / Article
-
Volume:
28
-
Publication Date:
2017
-
Doi Number:
10.1093/annonc/mdx365.007
-
Journal Name:
Annals of Oncology
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Istanbul University-Cerrahpasa Affiliated:
No